PointState Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-255,700
| Closed | -$12.6M | – | 113 |
|
|
2018
Q3 | $12.6M | Sell |
255,700
-1,366,984
| -84% | -$67.2M | 0.17% | 63 |
|
|
2018
Q2 | $52M | Sell |
1,622,684
-415,469
| -20% | -$13.3M | 0.59% | 39 |
|
|
2018
Q1 | $63.5M | Buy |
2,038,153
+847,146
| +71% | +$26.4M | 0.69% | 41 |
|
|
2017
Q4 | $54.4M | Buy |
1,191,007
+53,107
| +5% | +$2.42M | 0.53% | 47 |
|
|
2017
Q3 | $42.7M | Buy |
1,137,900
+566,400
| +99% | +$21.3M | 0.36% | 57 |
|
|
2017
Q2 | $27.3M | Sell |
571,500
-634,400
| -53% | -$30.3M | 0.3% | 57 |
|
|
2017
Q1 | $55M | Buy |
1,205,900
+361,900
| +43% | +$16.5M | 0.57% | 42 |
|
|
2016
Q4 | $27.3M | Buy |
844,000
+435,500
| +107% | +$14.1M | 0.39% | 60 |
|
|
2016
Q3 | $14M | Sell |
408,500
-191,500
| -32% | -$6.55M | 0.14% | 79 |
|
|
2016
Q2 | $20.2M | Buy |
600,000
+325,000
| +118% | +$11M | 0.42% | 37 |
|
|
2016
Q1 | $14.6M | Hold |
275,000
| – | – | 0.39% | 35 |
|
|
2015
Q4 | $21.1M | Sell |
275,000
-75,000
| -21% | -$5.76M | 0.54% | 32 |
|
|
2015
Q3 | $14.4M | Buy |
350,000
+25,000
| +8% | +$1.03M | 0.4% | 37 |
|
|
2015
Q2 | $23M | Buy |
325,000
+95,000
| +41% | +$6.72M | 0.27% | 55 |
|
|
2015
Q1 | $20.4M | Buy |
+230,000
| New | +$20.4M | 0.28% | 63 |
|